en

PRODUCT DETAIL

Sorafenib Pharmagen

Code 2911E
MA number 44/0041/23-S
Product Form: tbl flm 28x200 mg (blis.PVC/Aclar/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EX Other protein kinase inhibitors
L01EX02 Sorafenib
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 06.02.2023
Validity: 06.02.2028
PIL: PIL_Sorafenib Pharmagen_01_2023.pdf  
SPC: SPC_Sorafenib Pharmagen_01_2023.pdf  
Safety feature Yes
Data update: 08.02.2023
eu-flag.png sk-flag.png